Drugs / Onco-peptide loaded autologous dendritic cells
Onco-peptide loaded autologous dendritic cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00197925 | Sep 2004 → ? | breast cancer | Herlev Hospital | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Onco-peptide loaded autologous dendritic cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00197925 ↗ |
| Modality | Cell therapy | “autologous dendritic cells” NCT00197925 ↗ |
| Route | Other | “The vaccine is applied by either intranodal or intradermal injection near the inguinal region.” NCT00197925 ↗ |